iiinova — where your digital self keeps evolving

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 14h

🟣New from the #StemCellEvidence alert: ➡️ Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders by Pagliuca et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders by Pagliuca et al.
featured in the Stem Cell Evidence Alert - September 2026

111

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 05/10/2026

🆕From the #StemCellEvidence alert: ➡️Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group by Bazarbachi et al. 🔗Link in the comments #MedSky

$Image showing a PICO summary for: Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group by Bazarbachi et al. featured in the Stem Cell Evidence Alert - September 2026$

111

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 02/10/2026

🩸September was #SickleCellAwareness month and also saw the publication of our updated overview of #systematicreviews, looking at red cell #transfusion interventions in #sicklecelldisease, and led by Professor Lise Estcourt. @liseestcourt.bsky.social @thrinaline.bsky.social #MedSky

Image about the article: Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.

101

Reposted by Catherine Kimber

Jon Worth @jonworth.eu · 28/09/2026

Damn I am tired of people laughing about Deutsche Bahn. Travel in many other places in Europe and you will discover Germany is trying to do many things right with its railways. A quick blog post / rant from me: jonworth.eu/your-deutsche-… #CrossBorderRail

jonworth.eu

Your Deutsche Bahn "joke" is no longer funny (if it ever was)

Before attempting my record attempt between Kemijärvi, Finland and Lagos, Portugal, people told me over and over it would break down in Germany. So much so that I even tried to re-but (pre-but?) some of the likely critique. Now, having made the trip, and none of the total

2935290

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 17/09/2026

🟠Today we are celebrating #WorldPatientSafetyDay and also five years of the Transfusion Evidence Round-Up, which we produce in partnership with @isbt.bsky.social. 🔗Read more on the SRI website (link in replies)

Picture of the ISBT-SRI Transfusion Evidence Round-Up Team

143

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026

🟣 New from the #StemCellEvidence alert: 📑 Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes by Popat et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes
by Popat et al.
featured in the Stem Cell Evidence Alert - July/August 2026

132

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 01/09/2026

📆September is #BloodCancerAwarenessMonth. To honour this, episode 4 of our Talking Transfusion Podcast explores recent relevant findings, clinical challenges, and how transfusion supports those living with leukemia, lymphoma, myeloma, and related conditions. Links to the podcast here: bit.ly/45VghOf

bit.ly

Talking Transfusion Podcast

A collaborative podcast featuring the latest systematic reviews and trials

033

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 24/08/2026

#StemCellEvidence link to: Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell Transplantation by Ginosyan et al. www.stemcellevidence.com/alerts/artic...

stemcellevidence.com

https://www.stemcellevidence.com/alerts/articles/42276849

001

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 24/08/2026

#StemCellEvidence link to: The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy by Greco et al. www.stemcellevidence.com/alerts/artic...

stemcellevidence.com

https://www.stemcellevidence.com/alerts/articles/42203900

001

Reposted by Catherine Kimber

Transfusion Evidence Library @transfusionlib.bsky.social · 27/07/2026

✅New from the #TransfusionEvidence Alert: 🩸Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in #blooddonors by Geneen et al. 🔗Link in the comments #MedSky #blooddonation @thrinaline.bsky.social @willmcclune.bsky.social

Image showing a PICO summary for:
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in #blooddonors
by Geneen et al.
featured in the Transfusion Evidence Alert - July 2026

101

Reposted by Catherine Kimber

Transfusion Evidence Library @transfusionlib.bsky.social · 29/06/2026

🔴New from the #TransfusionEvidence Alert: Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled Trial by Biswas et al. 🔗Link in the comments. #MedSky

Image showing a PICO summary for:
Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled Trial
by Biswas et al.

featured in the Transfusion Evidence Alert - June 2026

112

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 29/06/2026

🆕The latest #StemCellEvidence alert is out! 🟣See the top 10 articles in the #StemCell Evidence Alert - June 2026. Each one has an easy-to-read PICO summary. 🔗Link in the comments #MedSky

Image showing an extract of the Stem Cell Evidence Alert - June 2026

112

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 23/06/2026

It is so exciting to be in the #ISBTCongress 2026, in Kuala Lumpur, learning, connecting, and presenting our research posters! @thrinaline.bsky.social @isbt.bsky.social #ISBTKualaLumpur #TransfusionMedicine

Image showing Catherine Kimber at ISBT Congress 2026

021

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 23/06/2026

What a privilege to participate in the #ISBTCongress 2026, advancing knowledge and collaborating with colleagues through poster presentations and workshops! @thrinaline.bsky.social @ericawood.bsky.social #ISBTKualaLumpur #TransfusionMedicine #ISBT #Transfusion

021

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 19/06/2026

✅You can also find more high-quality research about #SickleCell disease in the @transfusionlib.bsky.social and @stemcellevidence.bsky.social

001

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 10/06/2026

It's #NationalBloodWeek. This year's #NHSBT theme is 'we are the giving types because of you', recognising all areas of the organisation working to improve lives. Our role is in evidence synthesis and provision. You can access the latest publications on blood components use on our TEL bit.ly/4uhJVqt

Image showing results page from Transfusion Evidence Library 10 June 2026, with 'Blood Components' filter selected

015

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 04/06/2026

From the #StemCellEvidence alert: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study by Hansen et al. 🔗 Link in the comments #MedSky

$Image showing a PICO summary for: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study by Hansen et al. featured in the Stem Cell Evidence Alert - May 2026$

112

Reposted by Catherine Kimber

Transfusion Evidence Library @transfusionlib.bsky.social · 22/05/2026

New from the #TransfusionEvidence Alert: Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial by Afolabi et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial
by Afolabi et al.
featured in the Transfusion Evidence Alert

101

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 15/05/2026

From the #StemCellEvidence Alert: Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide by Smallbone et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide
by Smallbone et al.
featured in the Stem Cell Evidence Alert - April 2026

101

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 13/05/2026

From the #StemCellEvidence Alert: Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib by Massoud et al. Link in the comments #MedSky

Image showing a PICO summary for:
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib
by Massoud et al.
featured in the Stem Cell Evidence Alert - April 2026

111

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 12/05/2026

New from the #StemCellEvidence Alert: Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study by Malagola et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study
by Malagola et al.
featured in the Stem Cell Evidence Alert - April 2026

133

Reposted by Catherine Kimber

Helen Czerski @helenczerski.bsky.social · 10/05/2026

Good points in this piece from Chris Rapley: "Not once in the history of human spaceflight has an astronaut been known to tamper with their life support system... Sabotage is unthinkable – socially intolerable... We are doing to our planetary life support what no astronaut has done to theirs. "

theconversation.com

Why we need to treat Earth like a spaceship

Climate science is the anti-myth. Researchers have long noted that the human brain struggles with psychologically distant threats.

6299105

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 08/05/2026

Today is #InternationalThalassaemiaDay. In honour of this, the May Transfusion Evidence Round-Up and its accompanying podcast cover the topic of #thalassaemia. You can access the round-up articles here bit.ly/4cZONeJ, and the podcast here bit.ly/431jxG5

bit.ly

Transfusion Evidence Library

The Transfusion Evidence Library is a database of systematic reviews (since 1980) and randomised controlled trials (since 1950) relevant to transfusion medicine. It is fully searchable, updated monthl...

001

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 05/05/2026

New from the #StemCellEvidence Alert: Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy by Yang et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy
by Yang et al.
featured in the Stem Cell Evidence Alert - April 2026

101

Reposted by Catherine Kimber

Helen Czerski @helenczerski.bsky.social · 04/05/2026

How infuriating to hear the chairman(?) of Asda on the Today programme implying that land use for solar farms might significantly hurt UK food production. It's nonsense. Golf courses use more than solar ever will & beef/lamb production is huge yet provides a tiny fraction of our protein & calories.

Plot showing land use in the UK: predominantly beef and lamb pastures

911228422

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 25/04/2026

Today is #WorldMalariaDay. @who.int says progress against malaria is at risk, partly from drug resistance and diagnostic failure, showing the importance of quality, up to date evidence. You can filter by year to find recent reviews on malaria in our libraries- TEL bit.ly/4eGbuFO; SCEL bit.ly/4u9aQoR

bit.ly

Transfusion Evidence Library

The Transfusion Evidence Library is a database of systematic reviews (since 1980) and randomised controlled trials (since 1950) relevant to transfusion medicine. It is fully searchable, updated…

001

Reposted by Catherine Kimber

Systematic Review Initiative @sritransfusion.bsky.social · 24/04/2026

This week is #MSAwarenessWeek. The campaign #MSThinkAgain aims to develop understanding of the unpredictability of MS, and that no two people experience it the same. You can find high quality reviews seeking to understand MS and help those affected on our Stem Cell Evidence library bit.ly/4d1hMi2

bit.ly

Stem Cell Evidence

Stem Cell Evidence is a comprehensive collection of high quality research relevant to haematopoietic stem cell transplantation. Articles are pre-selected for clinical relevance and methodological qual...

002

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 09/03/2026

New from the #StemCellEvidence Alert: GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study by Yamasaki et al. #MedSky

Image showing a PICO summary for:

GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study
by Yamasaki et al.

featured in the Stem Cell Evidence Alert - February 2026

112

Reposted by Catherine Kimber

Helen Czerski @helenczerski.bsky.social · 09/03/2026

Oil prices wouldn't be all over the news today if more of our economy was powered by local, secure renewable energy. This isn't an "energy crisis". It's a fossil fuel crisis. 44% of UK electricity came from renewables in 2025. More of that plus an electrified economy => no more oil shocks.

Crude oil prices, showing a very sharp increase in the last day, from around 65 to 101 dollars per barrel..

872990875

Catherine Kimber @thrinaline.bsky.social · 27/02/2026

And that weird little buzzword "sectarianism" (completely misused) is in there again.

010

Reposted by Catherine Kimber

Transfusion Evidence Library @transfusionlib.bsky.social · 09/02/2026

From the #Transfusion Evidence Alert: Liberal versus restrictive red blood cell transfusion thresholds in acute acquired brain injury: a #systematicreview and #metaanalysis by Sud et al. www.transfusionevidencelibrary.com/articles/414... #MedSky

Image showing a PICO summary for:

Liberal versus restrictive red blood cell transfusion thresholds in acute acquired brain injury: a #systematicreview and #metaanalysis
by Sud et al.
featured in the Transfusion Evidence Alert - January 2026

001

Reposted by Catherine Kimber

Transfusion Evidence Library @transfusionlib.bsky.social · 05/02/2026

From the #Transfusion Evidence Alert: A standard blood bank donation improves cardiometabolic health of donors: A double-blind randomised controlled trial #blooddonation #blooddonors by Mora-Gonzalez et al. www.transfusionevidencelibrary.com/articles/413... #MedSky

Image showing a PICO summary for:
A standard blood bank donation improves cardiometabolic health of donors: A double-blind randomised controlled trial by Mora-Gonzalez et al.
Featured in the Transfusion Evidence Alert – January 2026

013

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 05/02/2026

New from the #StemCellEvidence Alert: Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation by Saultz et al. #MedSky www.stemcellevidence.com/articles/413...

Image showing a PICO summary for:
Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation
by Saultz et al.
featured in the Stem Cell Evidence Alert - January 2026

011

Reposted by Catherine Kimber

Dr. Aaron Thierry @thierryaaron.bsky.social · 13/01/2026

This thread responds to Prof. Christian Dunn’s Telegraph piece on #climate communication. I argue it misdiagnoses public disengagement, underplays escalating scientific risk, & reproduces a media narrative that has actively shaped, not merely reflected, public resistance to climate action 🧵

21411161

Reposted by Catherine Kimber

International Society of Blood Transfusion @isbt.bsky.social · 17/12/2025

New Talking Transfusion episode! In Perth Pearls with Pierre Tiberghien and Aaron Hess, the guests share their perspectives and memorable moments from Blood 2025/ISBT Perth 2025. Listen here: open.spotify.com/episode/6NQTkPGbk0… #TalkingTransfusion

open.spotify.com

Perth Pearls with Pierre Tiberghien and Aaron Hess

Talking Transfusion: The Transfusion Evidence Round-Up Podcast · Episode

023

Catherine Kimber @thrinaline.bsky.social · 30/12/2025

The home game in London zones 1&2 is the most fun you can have for the £8.90 daily fare cap.

010

Reposted by Catherine Kimber

Stem Cell Evidence @stemcellevidence.bsky.social · 19/12/2025

The #StemCellEvidence monthly alert is out! See the top 10 articles, read the PICO summaries, and subscribe to this alert here: www.stemcellevidence.com/alerts/latest #MedSky

Image showing an extract of the Stem Cell Evidence Alert - December 2025

045

Reposted by Catherine Kimber

ben doyle @thewheatgerm.bsky.social · 17/12/2025

THE TIME HAS COME

112128

Reposted by Catherine Kimber

Helen Czerski @helenczerski.bsky.social · 07/12/2025

TIL about a memorial ceremony in Iceland in 2019 to mark the end of a glacier, changing the place name from Okjökull to Ok (jökull = glacier). Uncompromising wording on the bronze plaque: "This is to acknowledge that we know what is happening and what needs to be done. Only you know if we did it".

Bronze plaque saying "A Letter to the Future. Ok is the first Icelandic glacier to lose its status as a glacier. In the next 200 years all our glaciers are expected to follow the same path. This monument is to acknowledge that we know what is happening and what needs to be done. Only you know if we did it. August 2019. 415ppm CO2"

113127235197